Cargando…
Elevation of Serum MAGE‐4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
Early detection of hepatocellular carcinoma (HCC) is clinically important because advanced HCC limits treatment modalities for the cancer. We have previously reported that serum levels of MAGE‐4 protein are strongly associated with the development of HCC. The present study was designed to determine...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927013/ https://www.ncbi.nlm.nih.gov/pubmed/11985796 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01277.x |
_version_ | 1783319010656387072 |
---|---|
author | Yutani, Shigeru Tanaka, Masatoshi Mutsumoto, Hajime Imai, Nobue Sata, Michio Shichijo, Shigeki Harada, Mamoru Itoh, Kyogo |
author_facet | Yutani, Shigeru Tanaka, Masatoshi Mutsumoto, Hajime Imai, Nobue Sata, Michio Shichijo, Shigeki Harada, Mamoru Itoh, Kyogo |
author_sort | Yutani, Shigeru |
collection | PubMed |
description | Early detection of hepatocellular carcinoma (HCC) is clinically important because advanced HCC limits treatment modalities for the cancer. We have previously reported that serum levels of MAGE‐4 protein are strongly associated with the development of HCC. The present study was designed to determine whether elevated serum MAGE‐4 protein levels can predict hepatocellular carcinogenesis in patients with liver cirrhosis before clinical diagnosis. Among 62 cirrhotic patients, 28 patients were diagnosed with HCC during the follow‐up period. The levels of MAGE‐4 protein and a‐fetoprotein (AFP) were significantly elevated in cirrhotic patients with HCC. Univariate and multivariate analyses suggest that elevated serum MAGE‐4 protein is more significant than AFP. Importantly, retrospective analysis of prefrozen sera of cirrhotic patients revealed a transient or continuous elevation of serum MAGE‐4 protein levels in 14 of 28 cirrhotic patients with HCC (50%) before clinical diagnosis. In contrast, elevated serum MAGE‐4 protein levels were observed in 3 of 33 cirrhotic patients without HCC (9%), and in 2 of 34 hepatitic patients (6%). These results indicate that elevated serum MAGE‐4 protein levels can be a predictive marker of hepatocellular carcinogenesis in cirrhotic patients, thereby enabling us to treat patients at an earlier stage. |
format | Online Article Text |
id | pubmed-5927013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-59270132018-05-11 Elevation of Serum MAGE‐4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis Yutani, Shigeru Tanaka, Masatoshi Mutsumoto, Hajime Imai, Nobue Sata, Michio Shichijo, Shigeki Harada, Mamoru Itoh, Kyogo Jpn J Cancer Res Article Early detection of hepatocellular carcinoma (HCC) is clinically important because advanced HCC limits treatment modalities for the cancer. We have previously reported that serum levels of MAGE‐4 protein are strongly associated with the development of HCC. The present study was designed to determine whether elevated serum MAGE‐4 protein levels can predict hepatocellular carcinogenesis in patients with liver cirrhosis before clinical diagnosis. Among 62 cirrhotic patients, 28 patients were diagnosed with HCC during the follow‐up period. The levels of MAGE‐4 protein and a‐fetoprotein (AFP) were significantly elevated in cirrhotic patients with HCC. Univariate and multivariate analyses suggest that elevated serum MAGE‐4 protein is more significant than AFP. Importantly, retrospective analysis of prefrozen sera of cirrhotic patients revealed a transient or continuous elevation of serum MAGE‐4 protein levels in 14 of 28 cirrhotic patients with HCC (50%) before clinical diagnosis. In contrast, elevated serum MAGE‐4 protein levels were observed in 3 of 33 cirrhotic patients without HCC (9%), and in 2 of 34 hepatitic patients (6%). These results indicate that elevated serum MAGE‐4 protein levels can be a predictive marker of hepatocellular carcinogenesis in cirrhotic patients, thereby enabling us to treat patients at an earlier stage. Blackwell Publishing Ltd 2002-04 /pmc/articles/PMC5927013/ /pubmed/11985796 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01277.x Text en |
spellingShingle | Article Yutani, Shigeru Tanaka, Masatoshi Mutsumoto, Hajime Imai, Nobue Sata, Michio Shichijo, Shigeki Harada, Mamoru Itoh, Kyogo Elevation of Serum MAGE‐4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis |
title | Elevation of Serum MAGE‐4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis |
title_full | Elevation of Serum MAGE‐4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis |
title_fullStr | Elevation of Serum MAGE‐4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis |
title_full_unstemmed | Elevation of Serum MAGE‐4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis |
title_short | Elevation of Serum MAGE‐4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis |
title_sort | elevation of serum mage‐4 protein levels and prediction of hepatocellular carcinogenesis in patients with liver cirrhosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927013/ https://www.ncbi.nlm.nih.gov/pubmed/11985796 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01277.x |
work_keys_str_mv | AT yutanishigeru elevationofserummage4proteinlevelsandpredictionofhepatocellularcarcinogenesisinpatientswithlivercirrhosis AT tanakamasatoshi elevationofserummage4proteinlevelsandpredictionofhepatocellularcarcinogenesisinpatientswithlivercirrhosis AT mutsumotohajime elevationofserummage4proteinlevelsandpredictionofhepatocellularcarcinogenesisinpatientswithlivercirrhosis AT imainobue elevationofserummage4proteinlevelsandpredictionofhepatocellularcarcinogenesisinpatientswithlivercirrhosis AT satamichio elevationofserummage4proteinlevelsandpredictionofhepatocellularcarcinogenesisinpatientswithlivercirrhosis AT shichijoshigeki elevationofserummage4proteinlevelsandpredictionofhepatocellularcarcinogenesisinpatientswithlivercirrhosis AT haradamamoru elevationofserummage4proteinlevelsandpredictionofhepatocellularcarcinogenesisinpatientswithlivercirrhosis AT itohkyogo elevationofserummage4proteinlevelsandpredictionofhepatocellularcarcinogenesisinpatientswithlivercirrhosis |